The Royal Victoria Regional Health Centre is an Advanced Level II facility with stroke designation, serving the needs of the population of the City of Barrie and the surrounding area. The facility is located at 201 Georgian Drive in Barrie, Ontario, Canada. The CEO is Janice Skot.

There are 319 beds in Royal Victoria Regional Health Centre.

During the past decade, Royal Victoria Regional Health Centre conducted 62 clinical trials. In the 10-year time frame, 62 clinical trials started and 29 clinical trials were completed, i.e. on average, 46.8% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 18 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Victoria Regional Health Centre" #1 sponsor was "Hoffmann-La Roche" with 18 trials, followed by "NCIC Clinical Trials Group" with 12 trials sponsored, "Canadian Cancer Trials Group" with 9 trials sponsored, "National Cancer Institute (NCI)" with 6 trials sponsored and "Alliance for Clinical Trials in Oncology" with 6 trials sponsored. Other sponsors include 58 different institutions and companies that sponsored additional 45 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Victoria Regional Health Centre" #1 collaborator was "National Cancer Institute (NCI)" with 10 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator and "SWOG Cancer Research Network" with 6 trials as a collaborator. Other collaborators include 84 different institutions and companies that were collaborators in the rest 73 trials.

According to Clinical.Site data, the most researched conditions in "Royal Victoria Regional Health Centre" are "Breast Cancer" (12 trials), "Colorectal Cancer" (5 trials), "Cervical Cancer" (3 trials), "Metastatic Breast Cancer" (3 trials) and "Pancreatic Cancer" (3 trials). Many other conditions were trialed in "Royal Victoria Regional Health Centre" in a lesser frequency.

Most popular intervention types in "Royal Victoria Regional Health Centre" are "Drug" (78 trials), "Other" (31 trials), "Procedure" (12 trials), "Radiation" (12 trials) and "Biological" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Paclitaxel" (8 trials), "Atezolizumab" (7 trials), "Docetaxel" (6 trials) and "Carboplatin" (5 trials). Other intervention names were less common.

The vast majority of trials in "Royal Victoria Regional Health Centre" are 83 trials for "All" genders, 26 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Royal Victoria Regional Health Centre". 3 are not yet recruiting, 16 are recruiting, 21 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 59 completed trials in Royal Victoria Regional Health Centre, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Royal Victoria Regional Health Centre, 2 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 62 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 16 trials that are defined as “Not Applicable".